PARK

EX-99.1

2 park-20260812xex99d1.htm

EX-99.1

Exhibit 99.1

Park Dental Partners Announces Second Quarter 2026 Results

FOR IMMEDIATE RELEASE

​

Minneapolis, Minn. — August 12, 2026 — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its second quarter financial results for 2026.  Summary financial results are listed below and in the accompanying supplemental financial tables.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

(Unaudited, in millions, except per share data,

​

Three Months Ended June 30,

​

​

Six Months Ended June 30,

​

and Doctor counts)

​ ​ ​

2026

​ ​ ​

​

2025

​ ​ ​

​

Change

​ ​ ​

​

2026

​ ​ ​

​

2025

​ ​ ​

​

Change

​

Revenue

$

66.2

​

$

63.0

​

​

5.1

%

​

$

128.9

​

$

122.0

​

​

5.6

%

Gross Margin

$

9.5

​

$

11.9

​

​

(20.1)

%

​

$

15.9

​

$

21.8

​

​

(27.0)

%

Gross Margin percentage

​

​

14.4

%

​

​

18.9

%

​

​

(450)

bps

​

​

12.3

%

​

​

17.8

%

​

​

(550)

bps

Net Income

​

$

1.3

​

$

2.6

​

​

(47.5)

%

​

$

1.0

​

$

4.1

​

​

(76.8)

%

Diluted EPS

​

$

0.22

​

$

1.45

​

$

(1.23)

​

​

$

0.16

​

$

2.33

​

$

(2.17)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Adjusted Gross Margin(a)

$

14.7

​

$

14.1

​

​

4.2

%

​

$

26.9

​

$

26.0

​

​

3.4

%

Adjusted Gross Margin Percentage(a)

​

​

22.2

%

​

​

22.4

%

​

​

(20)

bps

​

​

20.9

%

​

​

21.3

%

​

​

(40)

bps

Adjusted EBITDA(b)

$

7.4

​

$

7.6

​

​

(1.7)

%

​

$

12.2

​

$

13.0

​

​

(6.5)

%

Adjusted EBITDA margin(b)

​

​

11.2

%

​

​

12.0

%

​

​

(80)

bps

​

​

9.4

%

​

​

10.7

%

​

​

(130)

bps

Adjusted Diluted EPS(c)

$

0.66

​

$

1.88

​

$

(1.22)

​

​

$

1.11

​

$

3.02

​

$

(1.91)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Same Practice Revenue Growth

​

​

2.3

%

​

​

5.8

%

​

​

(350)

bps

​

​

3.2

%

​

​

3.6

%

​

​

(40)

bps

Practicing Affiliated Doctors

​

​

219

​

​

​

203

​

​

7.9

%

​

​

​

​

​

​

​

​

​

​

​

​

(a)

See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below

(b)

See Non GAAP Reconciliation of Net Income to Adjusted EBITDA below

(c)

See Non GAAP Reconciliation of Earnings Per Share to Adjusted Earnings Per Share below

​

Executive Commentary – Pete Swenson, Chief Executive Officer and Chair of the Board of Directors

​

“We delivered another quarter of revenue growth, supported by positive same-practice performance, strong patient retention, and continued expansion of our affiliated doctor base. Our underlying operations are performing well and generated strong operating cash flows during the quarter.

​

Patient demand across both general and specialty services remains resilient, and we continue investing in recruiting, staffing, clinical capacity, and strategic growth initiatives designed to support long-term value creation. Our balance sheet remains strong, providing flexibility to pursue disciplined acquisitions, support de novo expansion opportunities, and continue investing in our affiliated practices.”

​

Financial Results

​

●Revenue increased 5.1% to $66.2 million for the second quarter of 2026, compared to $63.0 million in the prior-year period. For the first six months of 2026, revenue increased 5.6% to $128.9 million, compared to $122.0 million in the prior-year period. The increases were primarily driven by acquisitions completed since the comparable prior-year periods, favorable reimbursement trends, and growth in clinical hours. Revenue from acquisitions in the past 12 months contributed approximately $1.3 million in the quarter and $2.0 million year-to-date.

●Gross profit was $9.5 million for the second quarter of 2026, compared to $11.9 million in the prior-year period. For the first six months of 2026, gross profit was $15.9 million, compared to $21.8 million in the prior-year period. Gross profit was impacted by higher salaries and benefits expense, including doctor share-based compensation associated with the Company's public company transition.

●Net income was $1.3 million, or $0.22 per diluted share, for the second quarter of 2026, compared to $2.6 million, or $1.45 per diluted share, in the second quarter of 2025. For the first six months of 2026, net income was $1.0 million, or $0.16 per diluted share, compared to $4.1 million, or $2.33 per diluted share, in the prior-year period.

●Adjusted EBITDA was $7.4 million for the second quarter of 2026, compared to $7.6 million in the prior-year period. For the first six months of 2026, Adjusted EBITDA was $12.2 million, compared to $13.0 million in the prior-year period.

●Adjusted diluted earnings per share was $0.66 for the second quarter of 2026, compared to $1.88 in the prior-year period. For the first six months of 2026, adjusted diluted ea

EX-99.1

2 tm2614439d1_ex99-1.htm

EXHIBIT 99.1

Exhibit 99.1

Park Dental Partners Announces First Quarter 2026 Results

FOR IMMEDIATE RELEASE

Minneapolis, Minn. — May 13, 2026 — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026. Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data, and Doctor counts)

Three Months Ended

March 31,

2026

2025

Change

Revenue

$ 62.7

$ 59.0

6.2 %

Gross Margin

$ 6.4

$ 9.9

(35.3 )%

Gross Margin percentage

10.2 %

16.7 %

(650 )bps

Net Income (Loss)

$ (0.4 )

$ 1.6

(124.9 )%

Diluted EPS

$ (0.09 )

$ 0.88

$ (0.97 )

Adjusted Gross Margin(a)

$ 12.2

$ 11.9

2.6 %

Adjusted Gross Margin Percentage(a)

19.5 %

20.2 %

(70 )bps

Adjusted EBITDA(b)

$ 4.7

$ 5.5

(13.2 )%

Adjusted EBITDA margin(b)

7.6 %

9.3 %

(170 )bps

Adjusted Diluted EPS(c)

$ 0.44

$ 1.14

$ (0.70 )

Same Practice Revenue Growth

4.1 %

1.2 %

290 bps

Practicing Affiliated Doctors

221

203

8.9 %

(a)See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below

(b)See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA below

(c)See Non GAAP Reconciliation of Earnings (Loss) Per Share to Adjusted Earnings Per Share below

Executive Commentary – Pete Swenson, Chief Executive Officer

and Chair of the Board of Directors

“We delivered a solid start to 2026, with revenue increasing 6.2% year over year, driven by strong same practice performance and continued patient demand. Results were consistent with our expectations and reflect continued execution against our operating plan. We continue to invest in recruiting, staffing, and clinical capacity to support long-term growth.

With strong liquidity and a flexible balance sheet, we remain well positioned to execute on our growth strategy, including expanding current practices and adding new practices through disciplined acquisitions and de novo expansion.”

Financial Results – First Quarter 2026

·Revenue increased 6.2% over the prior year’s comparable quarter to $62.7 million, due to increased patient visits and growth in clinical hours, the impact of acquisitions, and reimbursement growth. Same practice revenue growth was 4.1%. Revenue from acquisitions in the past 12 months contributed approximately $0.8 million in the quarter.

·Total General Practice revenue grew 6.4% over the prior year’s comparable quarter to $46.1 million. Total Multi-Specialty Practice revenue grew 5.7% to $16.6 million.

1

·Cost of services was $56.3 million, an increase of $7.1 million above the prior year’s comparable quarter, driven primarily by share-based compensation recorded in the quarter, and growth in doctors and team members.

·General and administrative costs were $7.8 million, an increase of $0.9 million above the prior year’s comparable quarter. The primary driver of these increases was share-based compensation, acquisition-related costs, and public company costs, net of lower IPO preparation costs related to our 2025 offering.

·Net loss was $(0.4) million, compared to net income of $1.6 million in the prior year comparable quarter, primarily driven by increased salaries and benefits, and share-based compensation, partially offset by revenue growth, tax benefits on share-based compensation, and operating leverage.

·Adjusted EBITDA was $4.7 million, or 7.6% of revenue, compared to $5.5 million, or 9.3% of revenue in the prior year comparable quarter.

·Adjusted diluted earnings per share were $0.44 versus $1.14 in the prior year’s comparable quarter, due primarily to the increase in shares issued and vested during the IPO.

Affiliated Practice Updates

·As of March 31, 2026, we supported 86 affiliated practices and 221 affiliated doctors.

·First quarter patient retention rate was 90.1%.

·Patient visits increased to 178,527 across our affiliated dental practices.

·During the first quarter our affiliated dental practices completed one general practice acquisition in Tucson, Arizona, as previously announced on January 23, 2026. The acquired practices’ impact on revenues and net earnings was not material for the quarter.

Balance Sheet, Liquidity, and Cash Flow

·Cash and cash equivalents were $24.4 million as of March 31, 2026.

·Total debt outstanding was approximately $11.5 million as of March 31, 2026, and our $15 million line of credit was undrawn at quarter end.

·Total shares outstanding were 4.5 million shares as of the end of the quarter.

·We generated $5.0 million in operating cash flow in the first quarter, a decrease of $0.8 million compared to the prior year comparable quarter due primarily to changes in working capital.

·First quarter capital investments were $2.3 million.

Full-Year 2026 Outlook

First quarter results were consistent with our expectations, and we are maintaining

EX-99.1

2 tm267177d1_ex99-1.htm

EXHIBIT 99.1

Exhibit 99.1

Park Dental Partners Announces Fourth Quarter and Full-Year Results

FOR IMMEDIATE RELEASE

Minneapolis, Minn. — February 25, 2026 — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its fourth-quarter and full-year financial results for 2025. Summary financial results are listed below and in the accompanying supplemental financial tables.

(Unaudited, in millions, except per share data, and Doctor counts)

Three Months Ended December 31,

Twelve Months Ended

December 31,

2025

2024

Change

2025

2024

Change

Revenue

$ 61.2

$ 56.9

7.5 %

$ 244.5

$ 229.8

6.4 %

Gross Margin

$ 2.5

$ 7.7

(67.9 )%

$ 33.7

$ 35.7

(5.6 )%

Gross Margin percentage

4.0 %

13.5 %

(950 )bps

13.8 %

15.5 %

(170 )bps

Net Income (Loss)

$ (5.7 )

$ (0.2 )

(2,264.2 )%

$ (0.4 )

$ 4.4

(108.2 )%

Diluted EPS

$ (2.31 )

$ (0.13 )

$ (2.18 )

$ (0.18 )

$ 2.42

$ (2.60 )

Adjusted Gross Margin(a)

$ 11.4

$ 9.8

15.7 %

$ 49.3

$ 44.0

11.9 %

Adjusted Gross Margin Percentage(a)

18.6 %

17.3 %

130 bps

20.1 %

19.2 %

90 bps

Adjusted EBITDA(b)

$ 3.7

$ 3.8

(1.9 )%

$ 22.0

$ 19.4

13.7 %

Adjusted EBITDA margin(b)

6.1 %

6.7 %

(60 )bps

9.0 %

8.4 %

60 bps

Adjusted Diluted EPS(c)

$ 0.30

$ (0.02 )

$ 0.32

$ 2.44

$ 3.17

$ (0.73 )

Same Practice Revenue Growth

6.3 %

(0.8 )%

5.8 %

1.6 %

Practicing Affiliated Doctors

214

206

3.9 %

214

206

3.9 %

(a)See Non GAAP Reconciliation of Gross Margin to Adjusted Gross Margin below

(b)See Non GAAP Reconciliation of Net Income (Loss) to Adjusted EBITDA below

(c)See Non GAAP Reconciliation of Earnings (Loss) Per Share to Adjusted Earnings Per Share below

Executive Commentary – Pete Swenson, Chief Executive Officer

and Chair of the Board of Directors

“We are pleased to report a strong finish to a very successful year. We achieved record revenue and adjusted EBITDA in 2025 and successfully completed our initial public offering in December. In the fourth quarter we maintained our momentum, as quarterly revenue grew 7.5% versus prior year and our patient retention rate remained strong at 89.9%, demonstrating our commitment to quality, patient-centered care. In addition, we maintained strong same practice revenue growth throughout the year, including 6.3% in the fourth quarter.”

“For 2026, our dedicated and talented doctors and team members have us well positioned to build on this performance and to continue our growth strategy. We anticipate a stable demand environment and we remain confident in our plans to deliver same practice growth. We continue to expect to complement our organic growth by adding affiliated practices and doctors that align with our mission, vision, and values.”

1

2025 Business and Operating Highlights

§Annual 2025 revenue grew 6.4% to $244.5 million, including 7.5% growth in the fourth quarter.

§Patient visits increased to 719,295 across our affiliated dental practices.

§Adjusted Gross Margin was $49.3 million, or 20.1% of revenue, an increase of 90 basis points from prior year.

§Adjusted EBITDA was $22.0 million, or 9.0% of revenue, an increase of 60 basis points from prior year.

§Annual operating cash flows were $17.6 million.

§December’s initial public offering (IPO) resulted in gross proceeds of $20.0 million, issuing 1,535,000 common shares at a price of $13.00 per share.

§Three acquisitions were completed in 2025, including two acquisitions on December 31.

Financial Results – Fourth Quarter

·Revenue of $61.2 million was $4.3 million above prior year comparable quarter due to increased patient visits, clinical hours, increased fee and reimbursement growth.

·General practice revenue grew 6.2% to $44.7 million. Multi-specialty practice revenue grew 11.3% to $16.5 million.

·Same practice revenue growth was 6.3% above prior year comparable quarter.

·Cost of services were $58.7 million, an increase of $9.5 million above prior year comparable quarter. General and administrative costs were $10.3 million, an increase of $4.3 million above prior year comparable quarter. The primary driver of these increases was share-based compensation expense associated with our IPO.

·Adjusted EBITDA was $3.7 million, approximately flat to the prior year comparable quarter.

·Adjusted EBITDA Margin was 6.1% or 60 basis points lower than prior year comparable quarter.

·Adjusted diluted earnings per share were $0.30 versus ($0.02) in the prior year comparable quarter.

Financial Results – Full Year 2025

·Revenue was $244.5 million, or $14.7 million above prior year due to increased patient visits and fee and reimbursement growth.

·General practice revenue grew 4.8% to $179.0 million. Multi-specialty practice revenue grew 11.0% to $65.5 million.

·Same practice revenue growth was 5.8% above prior year.

·Cost of services were $210.8 million, an increase of $16.7 million above prior yea